- Avelumab in the therapy of urothelial carcinoma2021 | First Faculty of Medicine
- Avelumab and its therapeutic use in uro-oncology2021 | Faculty of Medicine in Hradec Králové
- Combination avelumab-axitinib in metastatic renal cell carcinoma treatment2020 | First Faculty of Medicine
- Avelumab plus axitinib combination in treating metastatic renal cell carcinoma2022 | First Faculty of Medicine
- Avelumab as a maintenance therapy for advanced urothelial bladder carcinoma2023 | First Faculty of Medicine
- Combination of axitinib and avelumab in the treatment of metastatic renal cell carcinoma2022 | First Faculty of Medicine
- Combination therapy of avelumab and axitinib in a patient with renal cell carcinoma in a good prognostic group - case report2022 | Faculty of Medicine in Hradec Králové
- Dlouhodobé výsledky léčby avelumabem u pacientů s uroteliálním karcinomem2022 | First Faculty of Medicine
- Research Report University Hospital clinical trial EMR100070-001Publication without faculty affiliation
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. EMR100070-001Publication without faculty affiliation
- Merkel cell carcinoma - new treatment options2018 | First Faculty of Medicine
- Immunotherapy in non-melanoma skin cancer +12022 | First Faculty of Medicine
- Real-accesible novelties in immunotherapy from the perspective of a medical oncologist working in the Czech Republic2020 | Faculty of Medicine in Hradec Králové
- Effect of immunotherapy and radiotherapy in the treatment of Merkel cell carcinoma in a patient with myelodysplastic syndrome2023 | First Faculty of Medicine
- Merkel cell cancer2019 | Third Faculty of Medicine
- Current systemic treatment of bladder cancer2021 | First Faculty of Medicine
- Trial watch: Immune checkpoint blockers for cancer therapy2017 | Second Faculty of Medicine
- Výsledky studie JAVELIN Bladder 100 - průlom v léčbě uroteliálního karcinomu2021 | First Faculty of Medicine
- Immunotherapy in the treatment of lung cancer2017 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Immunotherapy of Renal Cell Carcinoma2017 | First Faculty of Medicine
- Immunotherapy for Bladder Cancer2017 | First Faculty of Medicine
- Imunoterapie v léčbě karcinomu močového měchýře2017 | Third Faculty of Medicine
- Gastrointestinal toxicity of systemic oncology immunotherapy2022 | First Faculty of Medicine, Central Library of Charles University
